| Primary |
| Attention Deficit/hyperactivity Disorder |
33.9% |
| Drug Use For Unknown Indication |
25.7% |
| Narcolepsy |
18.5% |
| Depression |
9.9% |
| Sleep Disorder |
3.1% |
| Sinusitis |
1.4% |
| Chronic Fatigue Syndrome |
1.0% |
| Psychomotor Hyperactivity |
1.0% |
| Affective Disorder |
0.7% |
| Anxiety |
0.7% |
| Fatigue |
0.7% |
| Somnolence |
0.7% |
| Antidepressant Therapy |
0.3% |
| Autoimmune Disorder |
0.3% |
| Emotional Disorder |
0.3% |
| Fibromyalgia |
0.3% |
| Generalised Anxiety Disorder |
0.3% |
| Head Injury |
0.3% |
| Hypersomnia |
0.3% |
| Hypertension |
0.3% |
|
| Drug Ineffective |
36.0% |
| Therapeutic Response Decreased |
8.7% |
| Pharmaceutical Product Complaint |
6.8% |
| Insomnia |
6.2% |
| Somnolence |
6.2% |
| Therapeutic Response Unexpected |
5.0% |
| Tricuspid Valve Incompetence |
3.1% |
| Vomiting |
3.1% |
| Fatigue |
2.5% |
| Overdose |
2.5% |
| Psychotic Disorder |
2.5% |
| Therapeutic Response Unexpected With Drug Substitution |
2.5% |
| Weight Increased |
2.5% |
| Adverse Event |
1.9% |
| Medication Error |
1.9% |
| Product Quality Issue |
1.9% |
| Sneezing |
1.9% |
| Thinking Abnormal |
1.9% |
| Weight Decreased |
1.9% |
| Drug Screen False Positive |
1.2% |
|
| Secondary |
| Narcolepsy |
32.8% |
| Attention Deficit/hyperactivity Disorder |
29.9% |
| Depression |
5.8% |
| Drug Use For Unknown Indication |
3.6% |
| Hypertension |
3.6% |
| Cataplexy |
2.9% |
| Fibromyalgia |
2.9% |
| Hypersomnia |
2.9% |
| Ill-defined Disorder |
2.9% |
| Anxiety |
2.2% |
| Schizoaffective Disorder |
2.2% |
| Chronic Fatigue Syndrome |
1.5% |
| Osteoporosis |
1.5% |
| Autoimmune Disorder |
0.7% |
| Bipolar Disorder |
0.7% |
| Generalised Anxiety Disorder |
0.7% |
| Major Depression |
0.7% |
| Neuropathy Peripheral |
0.7% |
| Pelvic Pain |
0.7% |
| Product Used For Unknown Indication |
0.7% |
|
| Drug Ineffective |
14.3% |
| Therapeutic Response Decreased |
12.5% |
| Somnolence |
8.9% |
| Psychotic Disorder |
7.1% |
| Weight Increased |
7.1% |
| Speech Disorder |
5.4% |
| Therapeutic Response Unexpected |
5.4% |
| Vomiting |
5.4% |
| Cardiac Valve Disease |
3.6% |
| Insomnia |
3.6% |
| Mood Altered |
3.6% |
| Overdose |
3.6% |
| Removal Of Foreign Body |
3.6% |
| Vomiting Projectile |
3.6% |
| Wrong Technique In Drug Usage Process |
3.6% |
| Apathy |
1.8% |
| Aphasia |
1.8% |
| Cardiac Murmur |
1.8% |
| Depressed Level Of Consciousness |
1.8% |
| Drug Effect Decreased |
1.8% |
|
| Concomitant |
| Drug Use For Unknown Indication |
18.4% |
| Product Used For Unknown Indication |
16.5% |
| Depression |
9.3% |
| Attention Deficit/hyperactivity Disorder |
8.3% |
| Bipolar Disorder |
6.5% |
| Narcolepsy |
5.1% |
| Multiple Sclerosis |
4.3% |
| Acne |
3.9% |
| Back Pain |
3.2% |
| Migraine |
3.1% |
| Sleep Disorder |
2.9% |
| Fatigue |
2.8% |
| Meniere's Disease |
2.5% |
| Pain |
2.5% |
| Gastrooesophageal Reflux Disease |
2.3% |
| Abnormal Behaviour |
1.7% |
| Anxiety |
1.7% |
| Hypertension |
1.7% |
| Hypothyroidism |
1.7% |
| Affective Disorder |
1.5% |
|
| Suicidal Ideation |
11.8% |
| Rectal Haemorrhage |
7.5% |
| Drug Ineffective |
6.5% |
| Weight Decreased |
6.5% |
| Nausea |
5.4% |
| Pancreatitis |
5.4% |
| Pancreatitis Acute |
5.4% |
| Tremor |
5.4% |
| Weight Abnormal |
5.4% |
| Aspartate Aminotransferase Increased |
4.3% |
| Multiple Sclerosis Relapse |
4.3% |
| Tardive Dyskinesia |
4.3% |
| Ulcer |
4.3% |
| Weight Increased |
4.3% |
| Abdominal Pain |
3.2% |
| Astrocytoma |
3.2% |
| Convulsion |
3.2% |
| Drug Prescribing Error |
3.2% |
| Menstruation Irregular |
3.2% |
| Osteonecrosis |
3.2% |
|
